Brief: Evofem Reaches Agreement With One Of The Largest Pharmacy Benefit Managers In The U.S. For Access To Phexxi
28/06/2022 11:51
June 28 (Reuters) - Evofem Biosciences Inc EVFM.O :
* EVOFEM REACHES AGREEMENT WITH ONE OF THE LARGEST PHARMACY
BENEFIT MANAGERS IN THE U.S. FOR ACCESS TO PHEXXI®
* EVOFEM BIOSCIENCES INC - EXPECTS INCREASES IN PHEXXI
PRESCRIPTIONS AND SIGNIFICANT COST-SAVINGS FROM AGREEMENTS
* EVOFEM BIOSCIENCES - STARTING ON JULY 1, 2022, EVOFEM
ANTICIPATES SAVING ABOUT $400,000 THROUGH END OF 2022 AND CLOSE
TO $1 MILLION ON AN ANNUALIZED BASIS
Source text for Eikon: ID:nPn9jbxPHa
Further company coverage: EVFM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evofem Biosciences
See all newsBrief: Evofem Biosciences Adds Additional Manufacturing Capacity For Phexx To Support Global Growth Strategy
Brief: HUB Cyber Security Expands Into Women's Health With Zero-Cash Acquisition Of Evofem Notes
Evofem Biosciences Q1 sales edge up on higher pricing
Evofem Biosciences Q3 net sales rise
Brief: Evofem Anticipates Approval Of Merger With Aditxt At Upcoming Stockholder Meeting